Cited by 2,010MicroRNA in disease regulationCancer-related Molecular PathwaysCancer-related molecular mechanisms research

The DOI matches its Crossref record; 55 of the 59 references it cites were found in a registry or an index.

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Open access

Chang, Tsung-Cheng, Wentzel, Erik A., Kent, Oliver A., Ramachandran, Kalyani, Mullendore, Michael, Lee, Kwang Hyuck, Feldmann, Georg, Yamakuchi, Munekazu, Ferlito, Marcella, Lowenstein, Charles J., Arking, Dan E., Beer, Michael A., Maitra, Anirban, Mendell, Joshua T.·2007·Molecular Cell

DOI 10.1016/j.molcel.2007.05.010PMC PMC1939978

Open this paper in CoChat — free account Open PDF

Abstract

The p53 tumor suppressor protein is a critical regulator of the cellular response to cancer-initiating insults such as genotoxic stress. In this report, we demonstrate that microRNAs (miRNAs) are important components of the p53 transcriptional network. Global miRNA expression analyses identified a cohort of miRNAs that exhibit p53-dependent upregulation following DNA damage. One such miRNA, miR-34a, is commonly deleted in human cancers and, as shown here, frequently absent in pancreatic cancer cells. Characterization of the miR-34a primary transcript and promoter demonstrates that this miRNA is directly transactivated by p53. Expression of miR-34a causes dramatic reprogramming of gene expression and promotes apoptosis. Much like the known set of p53-regulated genes, miR-34a-responsive genes are highly enriched for those that regulate cell-cycle progression, apoptosis, DNA repair, and angiogenesis. Therefore, it is likely that an important function of miR-34a is the modulation and fine-tuning of the gene expression program initiated by p53.

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2007.05.010

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Surfing the p53 network
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884

Flagged first, then by citations

Show all 59 references

4 of the 59 references couldn’t be matched to a known paper.

Sorted by citations

Items 501–600 of 1,000

An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
Salter, K. H., Acharya, C. R., Walters, K. S., Redman, R. C., Anguiano, A., Garman, K. S., Anders, C. K., Mukherjee, S., Dressman, H. K., Barry, W. T., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001908 · Cited by 89
Retracted
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus
Hashimoto, N., & Tanaka, T. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.150 · Cited by 93
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
Qiao, P., Li, G., Bi, W., Yang, L., Yao, L., & Wu, D. (2015) · BMC Cancer · doi:10.1186/s12885-015-1359-x · Cited by 89
Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway
Kim, H. J., Joe, Y., Yu, J. K., Chen, Y., Jeong, S. O., Mani, N., Cho, G. J., Pae, H., Ryter, S. W., & Chung, H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.017 · Cited by 91
Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression
Aherne, S. T., Madden, S. F., Hughes, D. J., Pardini, B., Naccarati, A., Levý, M., Vodička, P., Neary, P. C., Dowling, P., & CLYNES, M. M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1327-5 · Cited by 89
microRNAs in Cancer Cell Response to Ionizing Radiation
Czochor, J. R., & Glazer, P. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5718 · Cited by 90
microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
Gabra, M., & Salmena, L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00255 · Cited by 90
Regulation of B‐cell development and function by micro RNA s
de Yébenes, V. G., Bartolomé‐Izquierdo, N., & Ramiro, A. R. (2013) · Immunological Reviews · doi:10.1111/imr.12046 · Cited by 94
A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia
Sun, X., Zhang, J., Niu, W., Guo, W., Song, H., Li, H., Fan, H., Zhao, L., Zhong, A., Dai, Y., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32292 · Cited by 92
MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications
Rachagani, S., Kumar, S., & Batra, S. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.010 · Cited by 91
Long noncoding RNAs in the p53 network
Chaudhary, R., & Lal, A. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1410 · Cited by 88
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 89
p53, a translational regulator: contribution to its tumour-suppressor activity
Marcel, V., Catez, F., & Diaz, J. (2015) · Oncogene · doi:10.1038/onc.2015.25 · Cited by 94
MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
Peurala, H., Greco, D., Heikkinen, T., Kaur, S., Bártková, J., Jamshidi, M., Aittomäki, K., Heikkilä, P., Bártek, J., BLOMQVIST, C. P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026122 · Cited by 89
Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
Taucher, V., Mangge, H., & Haybaeck, J. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0275-7 · Cited by 89
Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
Yamada, Y. (2021) · Cancers · doi:10.3390/cancers13195002 · Cited by 92
MicroRNAs, the DNA damage response and cancer
Wouters, M. D., van Gent, D. C., Hoeijmakers, J. H. J., & Pothof, J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.03.012 · Cited by 90
Characterization of the p53 Cistrome – DNA Binding Cooperativity Dissects p53's Tumor Suppressor Functions
Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., & Stiewe, T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003726 · Cited by 87
p53 activates the PANK1/ miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins
Böhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
Reciprocal repression between TUSC7 and miR-23b in gastric cancer
Qi, P., Xu, M., Shen, X.-H., Ni, S., Huang, D., Tan, C., Weng, W., Sheng, W.-Q., Zhou, X.-Y., & Du, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29516 · Cited by 87
RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis
Gupta, S. M., & Mania‐Pramanik, J. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0520-2 · Cited by 91
Retracted
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Chen, Q., Yu, L., Tsang, P., Wei, J. S., Song, Y., Cheuk, A., Chung, J., Hewitt, S. M., Veenstra, T. D., & Khan, J. I. (2010) · Journal of Proteome Research · doi:10.1021/pr1006697 · Cited by 89
Senescence induction; a possible cancer therapy
LLeonart, M. E., Artero‐Castro, A., & Kondoh, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-3 · Cited by 90
miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration
Chen, Q., Yang, F., Guo, M., Wen, G., Zhang, C., Luong, L. A., Zhu, J., Xiao, Q., & Zhang, L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.017 · Cited by 86
A Small-Molecule Modulator of the Tumor-Suppressor miR34a Inhibits the Growth of Hepatocellular Carcinoma
Xiao, Z., Li, C. H., Chan, S. L., Xu, F., Lu, F., Wang, Y., Jiang, J.-D., Sung, J. J. �., Cheng, C. H. K., & Chen, Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0855 · Cited by 86
MicroRNAs as lung cancer biomarkers
Vescovo, V. D. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i4.604 · Cited by 88
Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil
Li, X., Zhao, H., Zhou, X., & Song, L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2726 · Cited by 90
MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance
Pedroza‐Torres, A., López–Urrutia, E., García-Castillo, V., Jacobo-Herrera, N. J., Herrera, L. A., Peralta-Zaragoza, Ó., López‐Camarillo, C., de León, D. F. C., Fernández‐Retana, J., Cerna-Cortés, J. F., et al. (2014) · Molecules · doi:10.3390/molecules19056263 · Cited by 86
Regulation of SIRT1 by MicroRNAs
Choi, S., & Kemper, J. K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0297-1 · Cited by 88
MicroRNAs and respiratory diseases
Rupani, H., Sánchez-Elsner, T., & Howarth, P. H. (2012) · European Respiratory Journal · doi:10.1183/09031936.00212011 · Cited by 87
EZH 2 coupled with HOTAIR to silence Micro RNA ‐34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma
Li, C., Xiao, Z., TONG, J. H. M., To, K., Fang, X., Cheng, A. S. L., & Chen, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30414 · Cited by 86
Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3
Chaudhary, R., Gryder, B. E., Woods, W. S., Subramanian, M., Jones, M. F., Li, X. L., Jenkins, L. M. M., Shabalina, S. A., Mo, M., Dasso, M., et al. (2017) · eLife · doi:10.7554/elife.23244 · Cited by 86
Circulating miR‐34a levels are reduced in colorectal cancer
Nugent, M., Miller, N., & Kerin, M. J. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23174 · Cited by 88
Micro-RNA-34a Contributes to the Impaired Function of Bone Marrow-Derived Mononuclear Cells From Patients With Cardiovascular Disease
Xu, Q., Seeger, F. H., Castillo, J., Iekushi, K., Boon, R. A., Farcas, R., Manavski, Y., Li, Y., Aßmus, B., Zeiher, A. M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.033 · Cited by 86
MicroRNAs in B cell development and malignancy
Fernando, T. R., Rodriguez-Malave, N. I., & Rao, D. S. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-7 · Cited by 89
MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3′ untranslated region
Tian, S., Huang, S., Wu, S., Guo, W., Li, J., & He, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.112 · Cited by 86
MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Expression of Synaptic and Autophagic Proteins
Morgado, A. L., Xavier, J. M., Dionísio, P. A., Ribeiro, M. F., Dias, R. B., Sebastião, A. M., Solá, S., & Rodrigues, C. M. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8794-6 · Cited by 88
MicroRNAs and Cardiovascular Diseases
Nishiguchi, T., Imanishi, T., & Akasaka, T. (2015) · BioMed Research International · doi:10.1155/2015/682857 · Cited by 83
Novel therapeutic targets for pancreatic cancer
Tang, S.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i31.10825 · Cited by 85
MicroRNAs in colorectal cancer: Small molecules with big functions
Yu, X., Yang, H., Zhao, L., Lau, W. B., Lau, B., Ren, N., Hu, Y., Yi, T., Zhao, X., Zhou, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.051 · Cited by 84
miRNAs and regulation of cell signaling
Ichimura, A., Ruike, Y., Terasawa, K., & Tsujimoto, G. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08087.x · Cited by 86
A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation
Hatano, K., Kumar, B., Zhang, Y., Coulter, J. B., Hedayati, M. A., Mears, B. M., Ni, X., Kudrolli, T. A., Chowdhury, W. H., Rodríguez, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv273 · Cited by 85
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 85
miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage
Salzman, D. W., Nakamura, K., Nallur, S. V., Dookwah, M., Metheetrairut, C., Slack, F. J., & Weidhaas, J. B. (2016) · Nature Communications · doi:10.1038/ncomms10954 · Cited by 87
Prediction of Associations between microRNAs and Gene Expression in Glioma Biology
Wuchty, S., Arjona, D., Li, A., Kotliarov, Y., Walling, J., Ahn, S. J., Zhang, A., Maric, D., Anolik, R., Zenklusen, J. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014681 · Cited by 83
Development of MicroRNAs as Potential Therapeutics against Cancer
Abd-Aziz, N., Kamaruzman, N. I., & Poh, C. L. (2020) · Journal of Oncology · doi:10.1155/2020/8029721 · Cited by 83
MicroRNAs in clinical oncology: at the crossroads between promises and problems
Metias, S., Lianidou, E. S., & Yousef, G. M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064717 · Cited by 83
Non‐coding RNAs in DNA damage and repair
Sharma, V., & Misteli, T. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.006 · Cited by 86
P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1
Li, Q., Kim, Y., Vikram, A., Kumar, S., Kassan, M., Gabani, M. H., Lee, S. K., Jacobs, J. S., & Irani, K. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308321 · Cited by 85
Regulation of Cardiac MicroRNAs by Bone Marrow Mononuclear Cell Therapy in Myocardial Infarction
Iekushi, K., Seeger, F. H., Aßmus, B., Zeiher, A. M., & Dimmeler, S. (2012) · Circulation · doi:10.1161/circulationaha.111.079699 · Cited by 83
Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53‐miR‐34a pathway
Wang, X., Meyers, C., Guo, M., & Zheng, Z. (2010) · International Journal of Cancer · doi:10.1002/ijc.25800 · Cited by 84
Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion
Bayraktar, R., Ivan, C., Bayraktar, E., Kanlikilicer, P., Kabil, N. N., Kahraman, N., Mokhlis, H. A., Karakaş, D., Rodriguez‐Aguayo, C., Arslan, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1959 · Cited by 83
Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
Xu, Y., Zhu, Y., Hu, S., Pan, X., Bawa, F. N. C., Wang, H. H., Wang, D. Q. ‐., Yin, L., & Zhang, Y. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101244 · Cited by 82
Differential MicroRNA-34a Expression and Tumor Suppressor Function in Retinoblastoma Cells
Dalgard, C. L., González, M. N., deNiro, J. E., & O’Brien, J. M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3520 · Cited by 81
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model
Lou, W., Chen, Q., Ma, L., Liu, J., Yang, Z., Shen, J., Cui, Y., Bian, X., & Qian, C. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0985-x · Cited by 82
Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis
McCleary‐Wheeler, A. L., Lomberk, G. A., Weiß, F. U., Schneider, G., Fabbri, M., Poshusta, T. L., Dusetti, N., Baumgart, S., Iovanna, J., Ellenrieder, V., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.005 · Cited by 86
Expression level of human miR-34a correlates with glioma grade and prognosis
Gao, H., Zhao, H., & Xiang, W. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1119-1 · Cited by 84
Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a
Kim, H.-Y., Kim, Y., & Hong, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-45924-3 · Cited by 81
miRNAs link metabolic reprogramming to oncogenesis
Hatziapostolou, M., Polytarchou, C., & Iliopoulos, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.002 · Cited by 84
MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients
Hafez, M. M., Hassan, Z. K., Zekri, A. N., Gaber, A. A., Rejaie, S. S. A., Sayed‐Ahmed, M. M., & Shabanah, O. A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.591 · Cited by 82
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
Schmid, G., Notaro, S., Reimer, D., Abdel-Azim, S. A.-F., Duggan-Peer, M., Holly, J., Fiegl, H., Rössler, J., Wiedemair, A., Concin, N., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2135-2 · Cited by 81
microRNA Control of Mouse and Human Pluripotent Stem Cell Behavior
Greve, T., Judson, R. L., & Blelloch, R. H. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122343 · Cited by 81
Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins
Harden, M. E., Prasad, N., Griffiths, A., & Münger, K. (2017) · mBio · doi:10.1128/mbio.02170-16 · Cited by 79
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 81
Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
Roy, B., Lee, E. J., Li, T., & Rampersaud, M. (2022) · Genes · doi:10.3390/genes13030425 · Cited by 83
Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance
Srivastava, S. K., Arora, S., Averett, C., Singh, S., & Singh, A. P. (2015) · BioMed Research International · doi:10.1155/2015/848710 · Cited by 84
MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2
Ma, Z., Hou, P.-P., Li, Y., Wang, D.-T., Yuan, T., Wei, J., Zhao, B., Lou, J., Zhao, X.-T., Jin, Y., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2861-5 · Cited by 82
Clinical Outcomes of TP53 Mutations in CancersPreprint
Robles, A. I., Jen, J., & Harris, C. C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026294 · Cited by 86
miR-34a in Neurophysiology and Neuropathology
Chua, C. E. L., & Tang, B. L. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1231-y · Cited by 84
miR-34a Modulates Angiotensin II-Induced Myocardial Hypertrophy by Direct Inhibition of ATG9A Expression and Autophagic Activity
Huang, J., Sun, W., Huang, H., Ye, J., Pan, W., Zhong, Y., Cheng, C., You, X., Liu, B., Xiong, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094382 · Cited by 80
Retracted
Identification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure
Bhaskaran, M., Dong, X., Wang, Y., Huang, C., Narasaraju, T. A., Shu, W., Zhao, C., Xiao, X., More, S., Breshears, M. A., et al. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00145.2011 · Cited by 81
Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells
Yu, X., Zhang, L., Wen, G., Zhao, H., Luong, L. A., Chen, Q., Huang, Y., Zhu, J., Ye, S., Xu, Q., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.206 · Cited by 79
A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck
Liu, Z., Wei, S., Ma, H., Zhao, M., Myers, J. N., Weber, R. S., Sturgis, E. M., & Wei, Q. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr209 · Cited by 78
Genome-wide analysis of microRNA and mRNA expression signatures in cancer
Li, M., Fu, S., & Xiao, H. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.67 · Cited by 80
MicroRNA and Cancer: Tiny Molecules with Major Implications
VandenBoom, T. G., Li, Y., Philip, P. A., & Sarkar, F. H. (2008) · Current Genomics · doi:10.2174/138920208784139555 · Cited by 78
A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis
Subramanian, M., Francis, P., Bilke, S., Li, X. L., Hara, T., Lu, X., Jones, M. F., Walker, R. L., Zhu, Y. J., Pineda, M. A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.46 · Cited by 79
Micro RNA ‐409‐3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression
Bai, R., Weng, C., Dong, H., Li, S., Chen, G., & Xu, Z. (2015) · International Journal of Cancer · doi:10.1002/ijc.29607 · Cited by 77
MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease
Wang, J., & Sen, S. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9083-4 · Cited by 81
The p53-signaling pathway and colorectal cancer: Interactions between downstream p53 target genes and miRNAs
Slattery, M. L., Mullany, L. E., Wolff, R. K., Sakoda, L. C., Samowitz, W. S., & Herrick, J. S. (2018) · Genomics · doi:10.1016/j.ygeno.2018.05.006 · Cited by 78
MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs.
Bhardwaj, A., Singh, S., & Singh, A. P. (2010) · PubMed · doi:10.4255/mcpharmacol.10.27 · Cited by 78
The impact of microRNAs on colorectal cancer
Faber, C., Kirchner, T., & Hlubek, F. (2009) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-009-0751-9 · Cited by 79
Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway
Suzuki, H. I., & Miyazono, K. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0650-1 · Cited by 80
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Kwon, M. J., & Shin, Y. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12020983 · Cited by 79
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling
Zhang, X., Ai, F., Li, X., Li, T. X., Wang, X., Shen, S., & Liu, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.6444 · Cited by 78
Identification of acute myeloid leukaemia associated microRNA expression patterns
Isken, F., Steffen, B., Merk, S., Dugas, M., Markus, B., Tidow, N., Zühlsdorf, M., Illmer, T., Thiede, C., Berdel, W. E., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06915.x · Cited by 77
Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues
Meng, W., McElroy, J. P., Volinia, S., Palatini, J., Warner, S., Ayers, L. W., Palanichamy, K., Chakravarti, A., & Lautenschlaeger, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064393 · Cited by 76
Apoptosis-associated microRNAs are modulated in mouse, rat and human neural differentiation
Aranha, M. M., dos Santos, D. M., Xavier, J. M., Low, W. C., Steer, C. J., Solá, S., & Rodrigues, C. M. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-514 · Cited by 77
Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective
Cau, P., Navarro, C. L., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, É., Perrin, S., Sandre‐Giovannoli, A. D., & Lévy, N. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.021 · Cited by 80
Recent updates on the role of microRNAs in prostate cancer
Hassan, O., Ahmad, A., Sethi, S. N., & Sarkar, F. H. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-9 · Cited by 77
Epigenetic regulation in lung cancer
Ramazi, S., Dadzadi, M., Sahafnejad, Z., & Allahverdi, A. (2023) · MedComm · doi:10.1002/mco2.401 · Cited by 82
MicroRNA 203 Expression in Keratinocytes Is Dependent on Regulation of p53 Levels by E6
McKenna, D. J., McDade, S. S., Patel, D., & McCance, D. J. (2010) · Journal of Virology · doi:10.1128/jvi.00703-10 · Cited by 79
MicroRNAs and apoptosis: implications in the molecular therapy of human disease
Yang, B., Lu, Y., & Wang, Z. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05245.x · Cited by 75
TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction networkPreprint
Krell, J., Stebbing, J., Carissimi, C., Dabrowska, A. F., de Giorgio, A., Frampton, A. E., Harding, V., Fulci, V., Macino, G., Colombo, T., et al. (2015) · Genome Research · doi:10.1101/gr.191759.115 · Cited by 77
Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
Murray, M. Y., Rushworth, S. A., Zaitseva, L., Bowles, K. M., & MacEwan, D. J. (2013) · Cell Cycle · doi:10.4161/cc.25251 · Cited by 75
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma
Ory, B., Ramsey, M. R., Wilson, C., Vadysirisack, D. D., Forster, N., Rocco, J. W., Rothenberg, S. M., & Ellisen, L. W. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43897 · Cited by 75
Convergent microRNA actions coordinate neocortical development
Barca‐Mayo, O., & Tonelli, D. D. P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1576-5 · Cited by 79
Epigenetic regulation of miRNA genes in acute leukemia
Agirre, X., Martinez-Climent, J. A., Odero, M. D., & Prósper, F. (2011) · Leukemia · doi:10.1038/leu.2011.344 · Cited by 76
Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
Sotillo, E., Laver, T., Mellert, H. S., Schelter, J. M., Cleary, M. A., McMahon, S. B., & Thomas‐Tikhonenko, A. (2011) · Oncogene · doi:10.1038/onc.2010.634 · Cited by 76
MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer
Lee, J., Voortman, J., Dingemans, A. C., Voeller, D. M., Pham, T. C., Wang, Y., & Giaccone, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021300 · Cited by 73
RETRACTED ARTICLE: p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death
Xiao, Y., Yan, W., Lu, L., Wang, Y., Lu, W., Cao, Y. L., & Cai, W. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026491 · Cited by 74
Retracted

Authors: Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., Arking, D. E., Beer, M. A., Maitra, A., & Mendell, J. T.
Affiliations: Johns Hopkins University (US)
Corresponding author: Mendell, Joshua T.
ORCID: Chang, Tsung-Cheng
Kent, Oliver A.
Ramachandran, Kalyani
Lee, Kwang Hyuck
Feldmann, Georg
Yamakuchi, Munekazu
Lowenstein, Charles J.
Arking, Dan E.
Beer, Michael A.
Maitra, Anirban
Mendell, Joshua T.
Venue: Molecular Cell
Publisher: Elsevier BV
Published: 2007-06
Volume: 26
Issue: 5
Pages: 745-752
ISSN: 1097-2765 (ISSN-L)
DOI: 10.1016/j.molcel.2007.05.010
PMC: PMC1939978
OpenAlex: W2038167014
Cited by: 2,010
References: 59
Citations by year: 2026: 23 · 2025: 37 · 2024: 34 · 2023: 47 · 2022: 54 · 2021: 94 · 2020: 84 · 2019: 89 · 2018: 94 · 2017: 116 · 2016: 121 · 2015: 133 · 2014: 186 · 2013: 159 · 2012: 177
FWCI: 45.22
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2274 d)
Locations: Molecular Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Rita Allen Foundation
Lustgarten Foundation
Allen Foundation
National Cancer Institute (R01CA113669, R01CA120185)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords: miR-34a, p53, DNA damage response, apoptosis, gene expression reprogramming, pancreatic cancer, cell cycle regulation, DNA repair, angiogenesis, tumor suppressor
MeSH terms: Base Sequence, DNA Damage, Humans, Pancreatic Neoplasms, Promoter Regions, Genetic, RNA, Neoplasm, Transcriptional Activation, Gene Expression, Tumor Suppressor Protein p53, Apoptosis, MicroRNAs, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks